Deerfield Management’s Editas Medicine EDIT Stock Holding History

Deerfield Management’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-538,721	Closed	-$37.8M	–	137
2020 Q4	$37.8M	Sell	538,721 -450,120	-46%	-$18.5M	0.75%	44
2020 Q3	$27.7M	Sell	988,841 -170,000	-15%	-$5.54M	0.68%	47
2020 Q2	$34.3M	Hold	1,158,841	–	–	1%	32
2020 Q1	$23M	Hold	1,158,841	–	–	0.73%	46
2019 Q4	$34.3M	Hold	1,158,841	–	–	1.09%	32
2019 Q3	$26.4M	Hold	1,158,841	–	–	1.07%	32
2019 Q2	$28.7M	Hold	1,158,841	–	–	1.03%	29
2019 Q1	$28.3M	Hold	1,158,841	–	–	1.09%	32
2018 Q4	$26.4M	Hold	1,158,841	–	–	1.06%	37
2018 Q3	$36.9M	Hold	1,158,841	–	–	1.32%	28
2018 Q2	$41.5M	Hold	1,158,841	–	–	1.46%	18
2018 Q1	$38.4M	Sell	1,158,841 -550,559	-32%	-$19.6M	1.33%	20
2017 Q4	$52.5M	Hold	1,709,400	–	–	2.07%	12
2017 Q3	$41M	Hold	1,709,400	–	–	1.85%	14
2017 Q2	$28.7M	Hold	1,709,400	–	–	1.53%	22
2017 Q1	$38.2M	Hold	1,709,400	–	–	1.47%	21
2016 Q4	$27.7M	Hold	1,709,400	–	–	1.14%	32
2016 Q3	$23M	Hold	1,709,400	–	–	1.07%	32
2016 Q2	$41.7M	Hold	1,709,400	–	–	1.64%	20
2016 Q1	$59M	Buy	+1,709,400	New	+$44.9M	2.51%	11

Other funds holding EDIT

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Deerfield Management's EDIT Position: Q1 2021 in Review

Deerfield Management sold out of Editas Medicine (EDIT) in Q1 2021, closing a stake of 538,721 shares — an estimated $37.8M sold.

Deerfield Management first reported a position in EDIT in Q1 2016 and held it in 20 quarters. The position peaked at $59M in Q1 2016. 312 funds tracked by Wall St. Rank hold EDIT as of Q1 2021.

Deerfield Management reported no remaining Editas Medicine position as of Q1 2021 after selling out during the quarter.
Deerfield Management sold 538,721 Editas Medicine shares in Q1 2021, an estimated $37.8M.
Deerfield Management first reported a position in Editas Medicine in Q1 2016 and held it in 20 quarters.
Deerfield Management's Editas Medicine position peaked at $59M in Q1 2016.
312 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2021.

Based on Deerfield Management's 13F filing for Q1 2021, filed 17 May 2021.